India to United States: Levothyroxine Export Trade Route

The India to United States Levothyroxine corridor is one of India's established pharmaceutical export routes, with 722 shipments documented worth a combined $42.5M USD. The route is dominated by MACLEODS PHARMACEUTICALS LTD, which alone accounts for roughly 56% of all export value, reflecting the consolidated nature of India's levothyroxine manufacturing sector.

Across 10 active suppliers, the average shipment value stands at $58.8K USD — a figure that reflects both bulk commercial orders from large pharmaceutical companies and smaller specialty shipments. Sea freight dominates at 79% of all shipments, consistent with levothyroxine's non-urgent bulk-order profile.

Shipment activity peaks during January–March, with an average transit time of 26 days port-to-port. The route has recorded an annual growth rate of 12.3%, placing it at rank #1 among India's top levothyroxine export destinations globally.

On the import side, key buyers of Indian levothyroxine in United States include MACLEODS PHARMA USA,INC,, EVERSANA LIFE SCIENCES SERVICES,LLC, EVERSANA LIFE SCIENCES SERVICES LLC and 22 others. MACLEODS PHARMA USA,INC, is the single largest importer with 16 shipments valued at $21.6M USD.

India's levothyroxine exports to United States are driven primarily by a handful of large-scale manufacturers. MACLEODS PHARMACEUTICALS LTD with 174 shipments leads the pack, a pattern common in generic pharmaceutical corridors where manufacturing scale creates significant cost advantages. The presence of 10 active exporters signals a competitive but concentrated market — buyers in United States benefit from supplier diversity while the top tier handles the majority of volume.

The top 3 suppliers — MACLEODS PHARMACEUTICALS LTD, INTAS PHARMACEUTICALS LIMITED, MYLAN LABORATORIES LIMITED — together account for 84% of total trade value on this route. The average shipment value of $58.8K USD reflects primarily bulk commercial orders from large pharmaceutical distributors.

Beyond the primary product category, shipments on this route include closely related formulations such as levothyroxine sodium tablets usp 137 mcg1x1000s (1348 pac) and levothyroxine sodium tablets usp 100 mcg1x1000s (1306 pac), suggesting that buyers in United States tend to consolidate orders across related product lines from the same Indian supplier.

On the buying side, MACLEODS PHARMA USA,INC, is the largest importer with 16 shipments worth $21.6M USD — representing 51% of all levothyroxine imports from India on this route. A total of 25 buyers are active on this corridor.